Edesa Biotech, Inc. Common Shares
EDSA XNAS
$7.02
+0.00 (+0.00%)
▲
15-min delayed
Open
N/A
High
N/A
Low
N/A
Volume
N/A
Market Cap
$64.95M
About Edesa Biotech, Inc. Common Shares
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
Key Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | N/A | $-2,247,669 | $-0.28 |
| FY 2025 | N/A | $-7,185,523 | $-1.27 |
| Q3 2025 | N/A | $-1,749,464 | $-0.25 |
| Q2 2025 | N/A | $-1,590,448 | $-0.30 |
Earnings & Analyst Ratings
Next Earnings:
Tue, May 12, 2026
Calendar →
TickerDaily Coverage
Why Is Edesa Biotech, Inc. Common Shares (EDSA) Stock Up 68% Today?
Penny Stocks
Marcus Rivera · Mar 3, 2026
Edesa Biotech (EDSA) stock exploded 68% Wednesday, climbing from $2.28 to $3.83 on accelerating...
Why Is Edesa Biotech, Inc. Common Shares (EDSA) Stock Up 73.0% Today?
Penny Stocks
Marcus Rivera · Mar 3, 2026
Edesa Biotech stock exploded 73% Wednesday, hitting $3.95 as market focus shifted to the expanding...
Why Is Edesa Biotech, Inc. Common Shares (EDSA) Stock Down 9.9% Today?
Penny Stocks
Marcus Rivera · Feb 25, 2026
Edesa Biotech, Inc. (EDSA) shares tanked 9.9% to $1.51 on light volume as the broader vitiligo...
EDSA Stock Surges 56.8% on Vitiligo Pipeline Catalyst: What Investors Need to Know
Penny Stocks
Marcus Rivera · Feb 25, 2026
Edesa Biotech (EDSA) ripped 56.8% higher to $1.51 on massive 97.7M-share volume — 271x the 30-day...
Why Is Edesa Biotech, Inc. Common Shares (EDSA) Stock Up 32.9% Today?
Penny Stocks
Marcus Rivera · Feb 24, 2026
Edesa Biotech, Inc. Common Shares (EDSA) ripped 32.9% higher to $1.1694 on 3.2M shares traded—8.9x...
View All Coverage →
Get EDSA Alerts
Stay ahead with breaking news, price alerts, and expert analysis on Edesa Biotech, Inc. Common Shares.
Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.